This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Maria Hristopoulos: Innovator in Antibody Drug Conjugates
Introduction
Maria Hristopoulos is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments using bispecific antibodies. Her work is instrumental in advancing therapeutic options for patients.
Latest Patents
Maria holds a patent titled "Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates." This patent reflects her expertise in creating targeted therapies that enhance the efficacy of cancer treatments.
Career Highlights
Maria is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her role at Genentech allows her to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Some of her notable coworkers include Klara Totpal and Michael C Wei. Together, they work on advancing the science of antibody drug conjugates, pushing the boundaries of what is possible in cancer therapy.
Conclusion
Maria Hristopoulos is a trailblazer in the field of biotechnology, with a focus on antibody drug conjugates. Her contributions are paving the way for new treatment options that can significantly impact patient care.